We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
NovoCure
NVCR
$2.04B
| $211K | ﹤0.01% |
+10,449
| New | +$201K |
|
2077
Embotelladora Andina Series B
AKO.B
| $210K | ﹤0.01% |
7,000
-1,100
| -14% | -$31K |
|
|
ACH
2078
DELISTED
Alum Corp of China Ltd
ACH
| $210K | ﹤0.01% |
+11,700
| New | +$222K |
|
2079
Korea Electric Power
KEP
$15.5B
| $209K | ﹤0.01% |
11,800
+800
| +7% | +$14K |
|
2080
Old Second Bancorp
OSBC
$1.24B
| $207K | ﹤0.01% |
+15,200
| New | +$202K |
|
|
SPWR
2081
DELISTED
SunPower Corporation Common Stock
SPWR
| $207K | ﹤0.01% |
+37,524
| New | +$194K |
|
2082
Neogen
NEOG
$2.05B
| $206K | ﹤0.01% |
6,675
-3,066
| -31% | -$92.9K |
|
|
SWCH
2083
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $206K | ﹤0.01% |
+11,300
| New | +$206K |
|
2084
Lifecore Biomedical
LFCR
$162M
| $204K | ﹤0.01% |
16,158
-1,200
| -7% | -$15.2K |
|
2085
Towne Bank
TOWN
$3.35B
| $202K | ﹤0.01% |
6,570
-2,777
| -30% | -$92.6K |
|
2086
Rocky Brands
RCKY
$304M
| $201K | ﹤0.01% |
10,650
| – | – |
|
|
TNAV
2087
DELISTED
Telenav Inc.
TNAV
| $200K | ﹤0.01% |
36,403
-3,400
| -9% | -$19K |
|
2088
Adtran
ADTN
$798M
| $199K | ﹤0.01% |
+10,285
| New | +$228K |
|
|
TVRD
2089
Tvardi Therapeutics
TVRD
$23.5M
| $198K | ﹤0.01% |
450
-25
| -5% | -$11.4K |
|
2090
Artivion
AORT
$1.23B
| $197K | ﹤0.01% |
10,274
-11,714
| -53% | -$235K |
|
|
GFA
2091
DELISTED
Gafisa S.A.
GFA
| $197K | ﹤0.01% |
+15,600
| New | +$161K |
|
|
SHLO
2092
DELISTED
Shiloh Industries Inc
SHLO
| $195K | ﹤0.01% |
23,800
+7,700
| +48% | +$70K |
|
2093
Lineage Cell Therapeutics
LCTX
$257M
| $194K | ﹤0.01% |
102,931
+83,214
| +422% | +$182K |
|
|
BPFH
2094
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $194K | ﹤0.01% |
12,526
-18,500
| -60% | -$295K |
|
2095
Marchex
MCHX
$79.7M
| $193K | ﹤0.01% |
59,800
-13,202
| -18% | -$42.2K |
|
|
NWHM
2096
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $193K | ﹤0.01% |
15,400
-2,600
| -14% | -$30.5K |
|
2097
Hecla Mining
HL
$10.2B
| $192K | ﹤0.01% |
+48,442
| New | +$211K |
|
2098
Smith & Wesson
SWBI
$655M
| $190K | ﹤0.01% |
+19,257
| New | +$208K |
|
|
AT
2099
DELISTED
Atlantic Power Corporation
AT
| $190K | ﹤0.01% |
80,801
+27,100
| +50% | +$66.5K |
|
|
RSYS
2100
DELISTED
Radisys Corp
RSYS
| $187K | ﹤0.01% |
186,000
+132,500
| +248% | +$142K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.